Mt. Sinai Medical Center, Miami   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Miami Beach FL United States (1946)

Organization Overview

First Clinical Trial
2002
NCT00158041
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Mt. Sinai Medical Center, Miami | Mt. Sinai Medical Center Miami Beach Florida

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma, Non-Small-Cell Lung (Phase 2)

Colonic Neoplasms (Phase 2)

Coronary Artery Disease (Phase 3)

Dysgeusia (Phase 1)

Head and Neck Neoplasms (Phase 4)

Heavy Metal Poisoning (Phase 4)

Infarction (Phase 3)

Ischemia (Phase 3)

Kidney Diseases (Phase 4)

Lung Neoplasms (Phase 2)

Melanoma (Phase 2)

Myocardial Infarction (Phase 3)

Peripheral Arterial Disease (Phase 1)

Peripheral Vascular Diseases (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 16
  • # of Trial APIs: 18